drugset / Trial / NCT04252625

Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis

NCT04252625 ↗

Phase 2 Terminated 10 enrolled University of Utah Farr Labs, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will assess the difference in prostatitis symptoms in men with localized prostate cancer following brachytherapy taking Q-Urol relative to placebo.

Timeline

Start
2022-11-14
Primary completion
2023-12-27
Completion
2024-01-25

Outcome

Outcome not reported

Stopped: “Drug Supply Issue”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Q-Urol Unknown — —